"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Shares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...

Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

It can be hard to sate investors’ appetites, but if there’s two companies who should know how to do it, it’s these two.

Kismet, an English Springer Spaniel, and her owner Stacey Yeoman have been bringing joy to patients and staff at Novant Health Mint Hill Medical Center for the past two months as a therapy dog team.

Cardiovascular disease continues to be the leading cause of death among women, claiming more lives annually than all forms of ...